Trials / Completed
CompletedNCT03334539
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
A Phase 2, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of Two Concentrations (0.10%, 0.25%) of HL036 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- HanAll BioPharma Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to compare the safety and efficacy of 0.10% and 0.25% HL036 Ophthalmic Solutions to placebo for the treatment of the signs and symptoms of dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HL036 ophthalmic solution | HL036 ophthalmic solution |
| OTHER | Placebo vehicle solution | Placebo vehicle solution |
Timeline
- Start date
- 2017-11-05
- Primary completion
- 2018-04-09
- Completion
- 2018-04-09
- First posted
- 2017-11-07
- Last updated
- 2024-03-07
- Results posted
- 2022-01-26
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03334539. Inclusion in this directory is not an endorsement.